These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 16415133)

  • 41. [Transjugular intrahepatic portosystemic shunt: evaluation of the impact of the stent's configuration on the patency rate].
    Schaefer PJ; Jahnke T; Schaefer FK; Hedderich J; Hinrichsen H; Heller M; Müller-Hülsbeck S
    Rofo; 2007 Sep; 179(9):965-70. PubMed ID: 17705118
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Survival in patients undergoing transjugular intrahepatic portosystemic shunt: ePTFE-covered stentgrafts versus bare stents.
    Angermayr B; Cejna M; Koenig F; Karnel F; Hackl F; Gangl A; Peck-Radosavljevic M;
    Hepatology; 2003 Oct; 38(4):1043-50. PubMed ID: 14512892
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Utility of transjugular intrahepatic portosystemic shunts in liver-transplant recipients.
    Choi DX; Jain AB; Orloff MS
    J Am Coll Surg; 2009 Apr; 208(4):539-46. PubMed ID: 19476787
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatic arterial buffer response in patients with advanced cirrhosis.
    Gülberg V; Haag K; Rössle M; Gerbes AL
    Hepatology; 2002 Mar; 35(3):630-4. PubMed ID: 11870377
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A new alternative for a transjugular intrahepatic portosystemic shunt: EUS-guided creation of an intrahepatic portosystemic shunt (with video).
    Buscaglia JM; Dray X; Shin EJ; Magno P; Chmura KM; Surti VC; Dillon TE; Ducharme RW; Donatelli G; Thuluvath PJ; Giday SA; Kantsevoy SV
    Gastrointest Endosc; 2009 Apr; 69(4):941-7. PubMed ID: 19327481
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transjugular intrahepatic portosystemic shunts in liver transplant recipients: technical analysis and clinical outcome.
    Saad WE; Darwish WM; Davies MG; Kumer S; Anderson C; Waldman DL; Schmitt T; Matsumoto AH; Angle JF
    AJR Am J Roentgenol; 2013 Jan; 200(1):210-8. PubMed ID: 23255764
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dacron-covered stent-grafts in transjugular intrahepatic portosystemic shunts: initial experience.
    Lau CT; Scott M; Stavropoulos SW; Soulen MC; Solomon JA; Clark TW
    Radiology; 2005 Aug; 236(2):725-9. PubMed ID: 16000648
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transjugular intrahepatic portosystemic shunt (TIPS) in the treatment of venous symptomatic chronic portal thrombosis in non-cirrhotic patients.
    Bilbao JI; Elorz M; Vivas I; Martínez-Cuesta A; Bastarrika G; Benito A
    Cardiovasc Intervent Radiol; 2004; 27(5):474-80. PubMed ID: 15383850
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transjugular intrahepatic portosystemic shunt (TIPS) in patients with refractory ascites: effect on body weight and Child-Pugh score.
    Trotter JF; Suhocki PV; Rockey DC
    Am J Gastroenterol; 1998 Oct; 93(10):1891-4. PubMed ID: 9772050
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increase in hepatic arterial blood flow after transjugular intrahepatic portosystemic shunt creation and its potential predictive value of postprocedural encephalopathy and mortality.
    Patel NH; Sasadeusz KJ; Seshadri R; Chalasani N; Shah H; Johnson MS; Namyslowski J; Moresco KP; Trerotola SO
    J Vasc Interv Radiol; 2001 Nov; 12(11):1279-84. PubMed ID: 11698626
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Transjugular intrahepatic portosystemic shunt in the treatment of Budd-Chiari syndrome with extensive occlusion of the hepatic veins].
    Wu XJ; Cao JM; Han JM; Li JS
    Zhonghua Wai Ke Za Zhi; 2006 Aug; 44(15):1029-32. PubMed ID: 17074238
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
    Colombato L
    J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Azygos blood flow: phase contrast quantitation in volunteers and patients with portal hypertension pre- and postintrahepatic shunt placement.
    Debatin JF; Zahner B; Meyenberger C; Romanowski B; Schöpke W; Marincek B; Fuchs WA
    Hepatology; 1996 Nov; 24(5):1109-15. PubMed ID: 8903384
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt insertion: a decade of experience.
    Masson S; Mardini HA; Rose JD; Record CO
    QJM; 2008 Jun; 101(6):493-501. PubMed ID: 18440957
    [TBL] [Abstract][Full Text] [Related]  

  • 55. TIPS: comparison of shunt patency and clinical outcomes between bare stents and expanded polytetrafluoroethylene stent-grafts.
    Jung HS; Kalva SP; Greenfield AJ; Waltman AC; Walker TG; Athanasoulis CA; Wicky ST
    J Vasc Interv Radiol; 2009 Feb; 20(2):180-5. PubMed ID: 19097918
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Distal splenorenal shunt versus transjugular intrahepatic portal systematic shunt for variceal bleeding: a randomized trial.
    Henderson JM; Boyer TD; Kutner MH; Galloway JR; Rikkers LF; Jeffers LJ; Abu-Elmagd K; Connor J;
    Gastroenterology; 2006 May; 130(6):1643-51. PubMed ID: 16697728
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Direct puncture of the recanalized paraumbilical vein for portal vein targeting during transjugular intrahepatic portosystemic shunt procedures: assessment of technical success and safety.
    Chin MS; Stavas JM; Burke CT; Dixon RG; Mauro MA
    J Vasc Interv Radiol; 2010 May; 21(5):671-6. PubMed ID: 20430297
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic capability of different liver disease scoring systems for prediction of early mortality after transjugular intrahepatic portosystemic shunt creation.
    Gaba RC; Couture PM; Bui JT; Knuttinen MG; Walzer NM; Kallwitz ER; Berkes JL; Cotler SJ
    J Vasc Interv Radiol; 2013 Mar; 24(3):411-20, 420.e1-4; quiz 421. PubMed ID: 23312989
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of ultrasound surveillance of transjugular intrahepatic portosystemic shunts in the covered stent era.
    Carr CE; Tuite CM; Soulen MC; Shlansky-Goldberg RD; Clark TW; Mondschein JI; Kwak A; Patel AA; Coleman BG; Trerotola SO
    J Vasc Interv Radiol; 2006 Aug; 17(8):1297-305. PubMed ID: 16923976
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of transjugular intrahepatic portosystemic shunt formation on portal hypertensive gastropathy and gastric circulation.
    Mezawa S; Homma H; Ohta H; Masuko E; Doi T; Miyanishi K; Takada K; Kukitsu T; Sato T; Niitsu Y
    Am J Gastroenterol; 2001 Apr; 96(4):1155-9. PubMed ID: 11316163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.